Serum lipid abnormalities (dyslipidemias) are major risk factors for cardiovascular disease in type 2 diabetes mellitus. Recent findings provide new evidence that dyslipidemia characterized by elevated triglycerides and non‐high‐density lipoprotein cholesterol levels with a decreased high‐density lipoprotein cholesterol level are risk factors for cardiovascular disease in patients with type 2 diabetes. There are multiple therapeutic agents to help patients to achieve target lipid levels, but understanding the molecular mechanisms could provide useful information for new treatment strategies for diabetic dyslipidemia.

中文翻译：

---

2型糖尿病，血脂异常和非酒精性脂肪肝疾病的新观点。

血清脂质异常（血脂异常）是2型糖尿病心血管疾病的主要危险因素。最新发现提供了新的证据，以甘油三酸酯升高和非高密度脂蛋白胆固醇水平升高，高密度脂蛋白胆固醇水平降低为特征的血脂异常是2型糖尿病患者心血管疾病的危险因素。有多种治疗剂可帮助患者达到目标血脂水平，但了解分子机制可为糖尿病血脂异常的新治疗策略提供有用的信息。